If you’ve received an exocrine pancreatic insufficiency (EPI) diagnosis, you might come across some new medical terms when talking with your doctor. Here are the most common ones to familiarize ...

EPI is a condition that occurs when the pancreas stops making enough digestive enzymes. Learn more about what causes it, how to spot the symptoms, and ways you can treat it. Most of us take digestion ...

March 1, 2012 — The US Food and Drug Administration (FDA) has approved 2 new pancreatic enzyme products to aid food digestion: pancrelipase delayed-release capsules (Ultresa, Aptalis Pharma) and ...

VIENNA, Austria — The appropriate dose of pancreatic enzyme replacement therapy (PERT) for exocrine pancreatic insufficiency (EPI) depends on the root cause of the insufficiency, according to results ...

A recent opinion piece by Struyvenberg et al. aims to address the existing myths, remove the current confusion, and function as a practical guide to the diagnosis and treatment of EPI. Exocrine ...

If your doctor suspects you may have exocrine pancreatic insufficiency (EPI), they’ll order a range of blood tests to check nutrient and enzyme levels. Share on Pinterest andresr/Getty Images While ...

HealthDay News — The FDA approved two drugs — Ultresa and Viokace, both manufactured by Aptalis Pharma — for patients with pancreatic enzyme deficiencies. Ultresa and Viokace are different ...

"Exocrine Pancreatic Insufficiency Market Report 2034"Exocrine Pancreatic Insufficiency companies are AbbVie, Nestle, Digestive Care, Inc., AzurRx BioPharma, Orlando Health, Inc., Chiesi Farmaceutici, ...

Exocrine pancreatic insufficiency, also known as EPI, is a condition that leads to a deficiency in exocrine pancreatic enzymes, and consequently an inability to digest food. The pancreas releases ...

The goals of PERT are to eliminate malabsorption, reduce maldigestion-related symptoms, and prevent malnutrition-related morbidity and mortality. Dosing and frequency of administration can be ...